RANBP2 evolution and human disease
FEBS Letters · 2023-10 · 597 (20) · 2519-2533
DOI: 10.1002/1873-3468.14749 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Letters, online erschienen am 15.10.2023. Verfasst von Sophie Desgraupes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Recherche en Infectiologie de Montpellier (IRIM), University of Montpellier, France. Hauptthemen laut MEDLINE: Nuclear Pore Complex Proteins, Molecular Chaperones. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Institut des sciences biologiques.
Abstract (Originalsprache)
Ran‐binding protein 2 (RANBP2)/Nup358 is a nucleoporin and a key component of the nuclear pore complex. Through its multiple functions (e.g., SUMOylation, regulation of nucleocytoplasmic transport) and subcellular localizations (e.g., at the nuclear envelope, kinetochores, annulate lamellae), it is involved in many cellular processes. RANBP2 dysregulation or mutation leads to the development of human pathologies, such as acute necrotizing encephalopathy 1, cancer, neurodegenerative diseases, and it is also involved in viral infections. The chromosomal region containing the RANBP2 gene is highly dynamic, with high structural variation and recombination events that led to the appearance of a gene family called RANBP2 and GCC2 Protein Domains ( RGPD ), with multiple gene loss/duplication events during ape evolution. Although RGPD homoplasy and maintenance during evolution suggest they might confer an advantage to their hosts, their functions are still unknown and understudied. In this review, we discuss the appearance and importance of RANBP2 in metazoans and its function‐related pathologies, caused by an alteration of its expression levels (through promotor activity, post‐transcriptional, or post‐translational modifications), its localization, or genetic mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Recherche en Infectiologie de Montpellier (IRIM), University of Montpellier, France.
- Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, UCBL1, CNRS UMR 5308, ENS de Lyon, Université de Lyon, France.
ORCID-Profile: Sophie Desgraupes, Lucie Etienne, Nathalie J Arhel
Förderung
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Institut des sciences biologiques
Zitieren
APA
Desgraupes, S., Etienne, L., & Arhel, N. J. (2023). RANBP2 evolution and human disease. FEBS Letters, 597(20), 2519-2533. https://doi.org/10.1002/1873-3468.14749
Vancouver
Desgraupes S, Etienne L, Arhel NJ. RANBP2 evolution and human disease. FEBS Letters. 2023;597(20):2519-2533. doi:10.1002/1873-3468.14749
BibTeX
@article{Desgraupes2023,
author = {Desgraupes, Sophie and Etienne, Lucie and Arhel, Nathalie J},
title = {RANBP2 evolution and human disease},
journal = {FEBS Letters},
year = {2023},
volume = {597},
number = {20},
pages = {2519--2533},
doi = {10.1002/1873-3468.14749}
}
EUVIMED